SCHEMBL29529691

SCHEMBL29529691

Fc1cc(N2CCCCC2)ccn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 2/20 0.54
▸ ELOVL1 Q9BW60 1/20 0.52
▸ CHKA P35790 2/20 0.50
▸ TERT O14746 3/20 0.46
▸ MAPT P10636 3/20 0.42
▸ S100B P04271 2/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ GAA P10253 2/20 0.42
▸ ALOX15 P16050 2/20 0.42
▸ HTT P42858 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ MAP4K4 O95819 1/20 0.41
▸ DHFR P00374 1/20 0.40
▸ SCN10A Q9Y5Y9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15918731 0.98 CHKA (0.52) HRH4ELOVL1CHKATERTMAPT
SCHEMBL21807915 0.81 HRH4 (0.59) HRH4MAPTMEN1GAAHTT
SCHEMBL31051504 0.81 HRH4 (0.59) HRH4MAPTMEN1GAAHTT
SCHEMBL27102997 0.81 ADRB2 (0.56) HRH4MAPTALDH1A1HTTTP53
SCHEMBL21807926 0.81 LMNA (0.46) MAPTMEN1ALDH1A1ALOX15HTT
SCHEMBL31051506 0.81 LMNA (0.46) MAPTMEN1ALDH1A1ALOX15HTT
Hydrochloric Acid SCHEMBL23302654 0.80 ADRB2 (0.55) HRH4MAPTALDH1A1HTTKDM4E
Hydrochloric Acid SCHEMBL29882400 0.80 ADRB2 (0.55) HRH4MAPTALDH1A1HTTKDM4E
SCHEMBL5847761 0.77 HRH4 (0.54) HRH4ELOVL1CHKATERTMAPT
SCHEMBL6262576 0.77 HRH4 (0.54) HRH4ELOVL1CHKATERTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250275952-A1 4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS MYOKARDIA INC (US) 2025-09-04 — — US disclosed
US-20220117955-A1 4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS MyoKardia, Inc. 2022-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250275952-A1 4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS TNNI3, UMPS, TNNT2 HRH4 1185/4885ELOVL1 3705/4885CHKA 2417/4885
US-20220117955-A1 4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS TNNI3, UMPS, TNNT2 HRH4 1185/4885ELOVL1 3705/4885CHKA 2417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback